Natural Oestrogen in the Female Climacteric - Influence on Blood Coagulation and Fibrinolysis

Summary

The aim of the present study was to investigate the effect on blood coagulation and fibrinolysis of a natural oestrogen preparation, piperazine oestrone sulphate, prospectively in menopausal women. Scopolamine was given to the control group.

The women were investigated before and during treatment with regard to factors VIII, VII, X, V, fibrinopeptide A, antithrombin III, plasminogen, rapid antiplasmin and α₁-antitrypsin. There was no significant change towards hypercoagulability or decreased fibrinolysis in any group. In the oestrogen group, however, a tendency towards an increased level of plasminogen and a decreased level of antiplasmin was demonstrated. In the scopolamine group there was an unexpected fall in factors X and V and also in plasminogen and α₁,-antitrypsin. A low level of some blood coagulation factors in some of the women before treatment is somewhat astonishing; none of them had any history of excessive bleeding.

• References

• 1 Abildgaard U, Lie M, ØDegård OR. 1976; A simple amidolytic method for the determination of functionally active antithrombin III. Scandinavian Journal of Clinical and Laboratory Investigation 36: 109
• 2 Alkjaersig N, Fletcher A, Burstein R. 1975; Association between oral contraceptive use and thromboembolism: A new approach to its investigation based on plasma fibrinogen chromatography. American Journal of Obstetrics and Gynecology 122: 199
• 3 Åstedt B. 1971; Low fibrinolytic activity of veins during treatment with ethinyl oestradiol. Acta Obstetricia et Gynecologica Scandinavica 50: 279
• 4 Aylward M, Maddock J, Rees P. 1976; Natural oestrogen replacement therapy and blood clotting. British Medical Journal 1: 220
• 5 Bachmann F, Duckert F, Roller F. 1958; The Stuart-Prower factor assay and its clinical significance. Thrombosis et Diathesis Haemorrhagica 2: 24
• 6 Brakman P. 1968. In: Astrup T, Wright IS. (ed.) Blood coagulation, thrombosis and female hormones. James F Mitchell Foundation; Washington: p 27
• 7 Blombäck M, Blombäck B, Holmqvist H. 1976; Immunological characterization of early fibrinogen degradation products. Radioimmunoassay of fragments released from the Aa-chain of fibrinogen Thrombosis Research 8: 567
• 8 Collen D, De Cock F, Verstraete M. 1975; Immunochemical distinction between antiplasmin and α1-antitrypsin. Thrombosis Research 7: 245
• 9 Coope J, Thomson JM, Poller L. 1975; Effects of “natural oestrogen” replacement therapy on menopausal symptoms and blood clotting. British Medical Journal 4: 139
• 10 Fagerhol MK, Abildgaard U. 1970; Immunological studies on human antithrombin III. Scandinavian Journal of Haematology 7: 10
• 11 Gjønaess H, Fagerhol MK. 1974; Studies on plasma coagulation and fibrinolysis during oral contraception of various types. Scandinavian Journal of Haematology 12: 232
• 12 Hedlin AM. 1975; The effect of oral contraceptive Estrogen on blood coagulation and fibrinolysis. Thrombosis Diathesis et Haemorrhagica 33: 370
• 13 Holmberg L, Nilsson IM. 1974; AHF related protein in clinical praxis. Scandinavian Journal of Haematology 12: 221
• 14 Howie PW, Mallinson AC, Prentice CR M, Horne CH W, McNicol GP. 1970; Effect of combined oestrogen-progestogen oral contraceptives, oestrogen and progestogen on antiplasmin and antithrombin activity. The Lancet 2: 1329
• 15 Kappeler R. 1955; Das Verhalten von Faktor V im Serum unter normalen und pathologischen Bedingungen. Zeitschrift fur klinische Medizin 153: 103
• 16 Von Kaulla KN. 1976; Oestrogens and blood coagulation. Triangle 15: 9
• 17 Kockum C. 1976; Radioimmunoassay of fibrinopeptide A - clinical application. Thrombosis Research 8: 225
• 18 Roller F, Loeliger A, Duckert F. 1951; Experiments on a new clotting factor(factor VII). Acta Haematologica 6: 1
• 19 Laurell C-B. 1966; Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analytical Biochemistry 15: 45
• 20 Mancini G, Carbonara A, Heremans JF. 1965; Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 235
• 21 Matsuda T. Coagulability of blood and fibrinolysis related to age and lipids. In: Vth Congress of the International Society of Thrombosis and Haemostasis; Paris: 07/1975. abstr 531
• 22 Nilsson IM, Blombäck M, Thilen A, Von Francken I. 1959; Carriers of hemophilia A. A laboratory study Acta Medica Scandinavica 165: 357
• 23 Meade TW, Brosovic M, Chakrabarti R, Howarth DJ, North WR S, Stirling Y. 1976; An epidemiological study of the haemostatic and other effects of oral contraceptives. British Journal of Haematology 34: 353
• 24 Müllertz S. 1974; Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin. Biochemical Journal 143: 273
• 25 Nilsson IM, Blombäck M, Von Francken I. 1957; On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin(AHG) deficiency and prolonged bleeding time. Acta Medica Scandinavica 159: 35
• 26 Nossel HL, Yudelman I, Canfield RE, Butler Jr VP, Spanondis R, Wilner GD, Qureshi GD. 1974; Measurement of fibrinopeptide A in human blood. Journal of Clinical Investigation 54: 43
• 27 ØDegård OR, Lie M, Abildgaard U. 1975. Heparin co-factor activity measured with an amidolytic method. Thrombosis Research, 6, 287 as modified by Ødegård in 1976(personal communication);
• 28 Poller L, Thomson JM. 1966; Clotting factors during oral contraception: further report. British Medical Journal 2: 23
• 29 Shanberge JN, Tanaka K, Gruhl MC, Ikemori R, Inoshita K. 1972; The effect of oral contraceptives on fibrin-clot stabilization. New York Academy of Science 202: 220
• 30 Stern MD, Givner ML. Studies on the mechanism of action of conjugated equine oestrogens. Symposium held at Charing Cross Medical School Hospital 11/1976
• 31 Teger-Nilsson AC, Friberger P, Gyzander E. 1977 Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. >Scandinavian Journal of Clinical & Laboratory Investigation. To be published
• 32 Vermylen C, De Vreeker RA, Verstraete M. 1963; A rapid enzymatic method for assay of fibrinogen fibrin polymerization time(FPT test). Clinica Chimica Acta 8: 418